Diamondback Energy Inc (NASDAQ:FANG), an oil and natural gas company, priced an underwritten public offering of 2,000,000 shares of its common stock by certain selling stockholders, of which 1,058,000 shares will be sold by certain entities controlled by Wexford Capital LP and 942,000 shares will be sold by Gulfport Energy Corporation (GPOR). Diamondback Energy Inc (NASDAQ:FANG) said that the underwriter intends to offer the shares from time to time for sale in one or more transactions on the NASDAQ Global Select Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.The total gross proceeds of the offering, before underwriter's discounts and commissions and estimated offering expenses, will be approximately $130.2 million, Diamondback Energy stated. The company added that all of the net proceeds from the offering would go to the selling stockholders. The underwriter has an option to purchase up to an additional 300,000 shares of common stock from the Wexford Entities. Over the past 52 weeks, the company has traded between $43.47 and $93.33.Click here for a free comprehensive Trend Analysis ReportBiocept Inc (NASDAQ:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor Cells, said it has launched lung cancer liquid biopsy testing. The tests will be performed at the company's CLIA-certified and CAP-accredited laboratory. By launching blood-based biomarker testing for non-small cell lung cancer, along with the previously commercialized breast cancer offering, Biocept Inc (NASDAQ:BIOC) is providing options for health care providers and researchers when a tumor biopsy is not available, is unsafe to perform or when additional information is desired, it said.Click here for a free comprehensive Trend Analysis ReportEZchip Semiconductor Ltd (NASDAQ:EZCH) on Wednesday reported weaker third quarter profits that still met analyst projections as carrier spending slowed following two record quarters earlier this year. The chip maker said Q3 net income, on a non-GAAP basis, was $8.5 million, or $0.28 per diluted share compared with non-GAAP net income of $10.1 million, or $0.33 per diluted share in the same period last year. Analysts expected net income of $0.28 per share, according to Capital IQ estimates. Revenue at the chip maker grew 2% to $19.2 million, about in line with estimates of $19 million. EZchip Semiconductor Ltd (NASDAQ:EZCH) CEO Eli Frachter said the slowdown in carrier spending is temporary. "Looking further out, carrier spending is forecasted to resume growth and with it, our corresponding sales into this market."Click here for a free comprehensive Trend Analysis Report
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
